PATENT CLAIM ANALYSIS

Application Number: 15760526
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "394000"]

Abstract:
The invention provides compounds and their pharmaceutical compositions according to Formula (I) that are useful for inhibiting RNA toxicity, such as in the treatment of myotonic dystrophy type 1, wherein W 1 , W 2 , W 3 , W 4 , L 1 , L 2 , and Cy are defined herein.

Claim (Index 12):
The method according to  claim 7 , wherein the cell is a mammalian cell.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.38095
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15427288', '14904999', '13851829', '14297037', '15412231']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7604587843246401
- 35 USC 102 Novelty (BERT): 0.5349158276652823
- Combined Prediction Score: 0.7379044886587043
- Mean Citation Score: 278.40387000000004
- Max Citation Score: 281.36847
- Similarity Product: 133.8254029219419

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test